FDA issues new safety alert on Reumofan Plus and Reumofan Plus Premium
date:Aug 22, 2012
leg cramps and withdrawal syndrome, and adrenal suppression.

Consumers who are taking these products or who have recently stopped taking Reumofan Plus or Reumofan Plus Premium should immediately consult a health care professional. Consumers should not buy or start using these products.

Ongoing FDA laboratory analyses of Reumofan Plus found that it contains the prescription drug ingredients:

dexamethasone a corticosteroid, commonly used to treat inflammatory conditions, that can impair the b
2/7 next page prev page home page last page
go back |  refresh |  WAP home |  Web page version  | login
05/01 21:00